Firefly Neuroscience, Inc. - Common Stock (AIFF)

3.3800Last Price

-0.1700 (-4.79%)Change

Firefly Neuroscience, Inc. is a pioneering company focused on developing innovative neurotechnology solutions aimed at enhancing the understanding and treatment of neurological conditions

The firm leverages advanced research and cutting-edge technology to create tools and therapies that enable more precise diagnosis and effective management of brain-related disorders. Through its commitment to scientific excellence and patient-centered approaches, Firefly strives to revolutionize the field of neuroscience, ultimately improving the quality of life for individuals affected by neurological diseases.

Innovative Stocks to Watch: PNPN.V, NMHI, PRSO, AIFF Leading Bold Industry Transformations – More Stocks Inside!

Discover the latest breakthroughs and strategic moves from industry-leading companies driving change across technology, healthcare, agriculture, and sustainability. From Nature's Miracle's game-changing investment deal to Power Nickel's high-potential mineral exploration, these organizations are setting the stage for innovation and growth in 2025.

Via AB Newswire · January 14, 2025

Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data

NEW YORK AND VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (Bright Minds or the Company) (NASDAQDRUG), a biotechnology company focused on developing novel therapies for neurological and neuropsychiatric disorders, today announced that it is once again collaborating with Firefly Neuroscience, Inc. (Firefly) NASDAQ: AIFFNASDAQAIFF)

By Bright Minds Biosciences · Via GlobeNewswire · October 21, 2024